Advisors from the U.S. Food and Drug Administration (FDA) are set to discuss this week whether seven widely-used peptides should be allowed to be compounded by licensed pharmacies. However, industry experts believe that regardless of the regulators' decision, consumer interest in these substances will likely remain high.This review comes as peptides transition from specialized anti-aging clinics into the expanding wellness sector, driven by social media influencers, biohacking communities, and support from Health Secretary Robert F. Kennedy Jr.Peptides, which are short sequences of amino acids, are claimed by supporters to enhance recovery, boost performance, and help with various health issues. Among those under evaluation are three popular...

On Friday, Prime Minister Mark Carney stated that the disgraced former prince Andrew Mountbatten-Windsor should be excluded from the line of succession due to...